In the present study, we investigated whether aversion to the pharmacological effects of ethanol developed to a differential extent in selectively bred Sardinian alcohol-preferring (sP) and Sardinian alcohol-nonpreferring (sNP) rats, and whether this different response was consistent with their genetically determined differences in ethanol preference and consumption. To this purpose, a conditioned taste aversion paradigm was used. Male sP and sNP rats were exposed to five sessions in which a 20-min availability of a saccharin solution (1 g/l) was paired to the injection of ethanol (0, 0.5, or 1 g/kg, i.p.), delivered immediately after removal of the saccharin bottle (conditioning phase). Subsequently, the choice between saccharin solution and water was offered for 18 consecutive daily 20-min sessions (postconditioning phase). Ethanol at 1g/kg produced a marked aversion to saccharin in sNP rats: The reduction in saccharin intake was already evident on the second day of the conditioning phase and lasted for 15 days of the postconditioning phase. In contrast, this dose of ethanol elicited a modest, if any, conditioned taste aversion in sP rats, although blood ethanol levels were comparable to those assessed in sNP rats. These results indicate the existence of a differential degree of aversion to the postingestional effects of ethanol between sP and sNP rats, and support the suggestion that it may contribute, at least in part, to the opposite preference for and consumption of ethanol monitored in these rat lines.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0741-8329(02)00195-7 | DOI Listing |
Front Endocrinol (Lausanne)
December 2024
Department of Ultrasound, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Background: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. Understanding the molecular mechanisms underlying PCOS is essential for developing effective treatments. This study aimed to identify hub genes and investigate potential molecular mechanisms associated with PCOS through a combination of bioinformatics analysis and Mendelian randomization (MR).
View Article and Find Full Text PDFDrug Dev Ind Pharm
November 2024
Department of Pharmaceutics, College of Pharmacy, Qassim University, Qassim, Saudi Arabia.
Background: Due to the toxicity and serious side effects of chemical incorporated in topical dosage form used for treatment of wound healing, there is a need to use natural preparation as wound healing preparation.
Aims: Seeds of (TFG) are used to synthesize eco-friendly silver nanoparticles (SNPs) in an appropriate way to heal wounds.
Methods: To synthesize SNPs, TFG was incubated with AgNO to produce SNP-TFG.
ACS Omega
December 2024
Laboratório de Química Biológica (LQB), Departamento de Química Orgânica, Instituto de Química, and INCT-Bio (CNPq), Universidade Estadual de Campinas (UNICAMP), Campinas, SP 13083-970, Brazil.
Schizophrenia (SCZ) is a multifactorial mental illness with limited knowledge concerning pathogenesis, contributing to the lack of effective therapies. More recently, the use of a nitric oxide donor named sodium nitroprusside (sNP) was suggested as a potential therapeutic drug for the treatment of SCZ. Despite the mixed results regarding the effectiveness of the sNP in reducing SCZ symptoms, successful trials on sNP in treatment-resistant SCZ were published.
View Article and Find Full Text PDFHypertens Res
December 2024
Institute for Fetology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China.
Many epidemiologic and animal studies have shown that maternal hypothyroidism is associated with an increased risk of hypertension in offspring in later life. In this study, we established a maternal hypothyroidism rat model to explore the underlying mechanism that contributes to elevated blood pressure in adult male offspring of hypothyroid mothers. The levels of thyroid hormones (THs) in the offspring were measured using ELISA kits.
View Article and Find Full Text PDFNeurochem Res
November 2024
Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC, 29425, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!